Dr. Pegram on Pertuzumab Combination for HER2-Positive Breast Cancer

Dr. Pegram on Pertuzumab Plus Trastuzumab and Chemotherapy in Breast CancerПодробнее

Dr. Pegram Discusses Adjuvant Pertuzumab in HER2+ Breast CancerПодробнее

Dr. Pegram on Pertuzumab and Trastuzumab in Breast CancerПодробнее

Dr. Pegram on Challenges Facing the Treatment of HER2-Positive Breast CancerПодробнее

Dr. Yee on Neoadjuvant Pertuzumab in HER2-Positive Breast CancerПодробнее

Dr. Mark Pegram on Combining Trastuzumab and PertuzumabПодробнее

Dr. Pegram on Neoadjuvant Treatments for HER2-Postive Breast CancerПодробнее

Dr. Pegram on Challenges in Neoadjuvant Treatment for HER2-Positive Breast CancerПодробнее

Dr. Pegram on Sequencing Therapies in HER2-Positive Breast CancerПодробнее

Dr. Pegram Discusses the Use of Neratinib in HER2+ Breast CancerПодробнее

Study of Atezolizumab with Pertuzumab and Trastuzumab in HER2- Positive Metastatic Breast CancerПодробнее

Dr. Hamilton Discusses Challenges With Approved Treatments for HER2-Positive Breast CancerПодробнее

A presurgery combination therapy may improve outcomes for women with HER2 positive breast cancerПодробнее

Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival outcomes in HR and HE...Подробнее

Pertuzumab, trastuzumab and cyclophosphamide in older patients with HER2+ breast cancerПодробнее

DESTINY-Breast07: T-DXd+/- pertuzumab in patients with metastatic HER2+ breast cancerПодробнее

How Perjeta (Pertuzumab) is Used to Treat HER2-Positive Breast CancerПодробнее

PRECIOUS: pertuzumab retreatment in patients with HER+ breast cancerПодробнее

Dr. Pegram on Margetuximab Plus Chemo in HER2+ Breast CancerПодробнее